Healthsmile

Healthsmile
Stealth ModeAI-powered dental care platform providing instant virtual dental consultations and personalized oral health assessments.
About
What does Healthsmile do?
Healthsmile leverages artificial intelligence to offer users instant, virtual dental checkups and personalized oral health assessments. By analyzing user-submitted photos and symptoms, the platform delivers actionable insights and connects patients with dental professionals for further care.
Is Healthsmile trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Healthsmile is 26 out of 100, based on site security posture and privacy practices.
When was Healthsmile founded?
Healthsmile was founded in 2026.
What industry does Healthsmile operate in?
Healthsmile operates in MedTech, HealthTech, Telemedicine, AI Chatbot, Consumer App, Generative AI.
Medbytes provides doctors with a personalized platform for high-impact medical research and news in their specialty.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
An AI-powered platform for cancer patients and survivors in Asia to navigate care and understand their diagnosis.
Your health consultation for a pain-free life, offering pain management and therapy solutions.
AI-powered personalized sleep coaching and actionable insights for improving sleep quality.
SomaIQ drafts the interpretation and patient explanation for your review, reducing a 90-minute task to five.
AI-powered digital health platform offering personalized nutrition and wellness plans based on individual metabolism.
Akylmed is developing an AI-powered platform to streamline medical documentation and administrative tasks for healthcare providers.
An entrant is a company tagged MedTech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 1 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.